Compile Data Set for Download or QSAR
Report error Found 134 of ic50 data for polymerid = 50001306
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM4552(CHEMBL288441 | SKI-606 | 4-[(2,4-Dichloro-5-methox...)
Affinity DataIC50: 0.5nMAssay Description:Inhibition of ABL2More data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM50427749(CHEMBL2324924)
Affinity DataIC50: 1nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM50427749(CHEMBL2324924)
Affinity DataIC50: 2nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM50427748(CHEMBL2324925)
Affinity DataIC50: 3nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM378885(US10266537, Compound 93)
Affinity DataIC50: 4nMAssay Description:The aim of this experiment is to detect the inhibitory activity of the compounds of the present invention against in vitro protein kinases using isot...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM378885(US10266537, Compound 93)
Affinity DataIC50: 4nMAssay Description:Inhibition of human recombinant ARG (38 to end residues) using EAIYAAPFAKKK as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM50427747(CHEMBL2324926)
Affinity DataIC50: 6nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM50427742(CHEMBL2324930)
Affinity DataIC50: 8nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM50427748(CHEMBL2324925)
Affinity DataIC50: 10nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataIC50: 10.1nMAssay Description:Inhibition of human ABL2 using EAIYAAPFAKKK as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM50427750(CHEMBL2324923)
Affinity DataIC50: 11nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM50427745(CHEMBL2324927)
Affinity DataIC50: 12nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM50427744(CHEMBL2324928)
Affinity DataIC50: 14nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM50427750(CHEMBL2324923)
Affinity DataIC50: 15nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataIC50: 15.8nMAssay Description:Inhibition of human ABL2 using EAIYAAPFAKKK as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM50427741(CHEMBL2324931)
Affinity DataIC50: 18nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM481113(US10906896, Cpd 117)
Affinity DataIC50: 35nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM612783(US11725005, Compound 117)
Affinity DataIC50: 35nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM50427743(CHEMBL2324929)
Affinity DataIC50: 36nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM50427742(CHEMBL2324930)
Affinity DataIC50: 39nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM481131(US10906896, Cpd 8300 | US10906896, Cpd 832 | US117...)
Affinity DataIC50: 39nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM612893(US11725005, Compound 8300)
Affinity DataIC50: 39nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM50427740(CHEMBL2324932)
Affinity DataIC50: 40nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM50427741(CHEMBL2324931)
Affinity DataIC50: 41nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM481115(US10906896, Cpd 119)
Affinity DataIC50: 44.7nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM612785(US11725005, Compound 119)
Affinity DataIC50: 44.7nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM50427747(CHEMBL2324926)
Affinity DataIC50: 47nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM481109(US10906896, Cpd 113)
Affinity DataIC50: 50.1nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM612772(US11725005, Compound 113)
Affinity DataIC50: 50.1nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM481114(US10906896, Cpd 118)
Affinity DataIC50: 51nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM481130(US10906896, Cpd 830 | US11725005, Compound 830)
Affinity DataIC50: 51nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM612784(US11725005, Compound 118)
Affinity DataIC50: 51nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM481130(US10906896, Cpd 830 | US11725005, Compound 830)
Affinity DataIC50: 51nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM50427744(CHEMBL2324928)
Affinity DataIC50: 66nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM50427743(CHEMBL2324929)
Affinity DataIC50: 67nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM481107(US10906896, Cpd 107)
Affinity DataIC50: 67nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM612764(US11725005, Compound 107)
Affinity DataIC50: 67nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM481119(US10906896, Cpd 207)
Affinity DataIC50: 73.7nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM612791(US11725005, Compound 207)
Affinity DataIC50: 73.7nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataIC50: 76nMAssay Description:Inhibition of ARG (unknown origin) incubated for 1 hr by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM481128(US10906896, Cpd 809 | US11725005, Compound 809)
Affinity DataIC50: 77nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM481131(US10906896, Cpd 8300 | US10906896, Cpd 832 | US117...)
Affinity DataIC50: 77nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM481128(US10906896, Cpd 809 | US11725005, Compound 809)
Affinity DataIC50: 77nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM481131(US10906896, Cpd 8300 | US10906896, Cpd 832 | US117...)
Affinity DataIC50: 77nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM481108(US10906896, Cpd 108)
Affinity DataIC50: 85.9nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM612767(US11725005, Compound 108)
Affinity DataIC50: 85.9nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM481137(US10906896, Cpd 8190 | US11725005, Compound 8190)
Affinity DataIC50: 91nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM481137(US10906896, Cpd 8190 | US11725005, Compound 8190)
Affinity DataIC50: 91nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM481143(US10906896, Cpd 8270 | US11725005, Compound 8270)
Affinity DataIC50: 100nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetTyrosine-protein kinase ABL2(Human)
Center For Molecular Medicine of The Austrian Academy of Sciences

Curated by ChEMBL
LigandPNGBDBM481143(US10906896, Cpd 8270 | US11725005, Compound 8270)
Affinity DataIC50: 100nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

Displayed 1 to 50 (of 134 total ) | Next | Last >>
Jump to: